The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaClaudio Festuccia, Thomas Mehrling|Journal of Hematology & Oncology|2018Cited by 57